miR-200 family as new potential prognostic factor of overall survival of patients with WHO G2 and WHO G3 brain gliomas
Authors:
Preprint
- 16 October 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose Gliomas are the predominant cause of cancer-related deaths among the young population. Even after incorporation of IDH1/2 mutations and 1p19q codeletion there are doubts regarding adjuvant treatment in WHO G2/G3 gliomas. miRNA molecules control about 30% of all genes, also many oncogenes, tumor suppressor genes and genes responsible for the response to ionizing radiation and systemic treatment. Patients with brain gliomas exhibit miRNA disorders. We aimed to evaluate the expression of miR-200 family members in relation to selected clinico- pathological factors and their prognostic value. Material/Methods We enrolled 53 patients diagnosed with WHO G2/G3 brain gliomas treated between 2012–2016. RT-qPCR based expression of miR-200 family was assessed in tumor and surrounding non-cancerous tissue. An analysis of selected clinico- pathological features was carried out. A logistic regression model was prepared for the miRNA signature. The predictive potential of the signature was assessed using the ROC curve. A stepwise backward regression model was used to select variables with a significant predictive potential related to OS. Results It was shown that miR-200a-3p, miR-200a-5p, miR-200c-5p, miR-141-3p and miR-429 can be independent predictors of survival. Better 2- and 5-year OS was associated with higher expression of miR-200a-3p, miR141-3p and lower expression of miR-200a-5p, miR-200c-5p, miR-429. The strongest predictors of survival were miR-200a-5p, miR-200b-3p, miR-200c-5p, miR-141-3p, miR-429, tumor volume and CTV. Conclusion Members of the miR-200 family exhibit prognostic value for 2- and 5-year OS. Presented predictive models of survival may be clinically useful for treatment optimization.Keywords
All Related Versions
- Version 1, 2024-10-16, Research Square
- Published version: Scientific Reports, 14 (1), 1.
This publication has 51 references indexed in Scilit:
- Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimatorComputer Methods and Programs in Biomedicine, 2019
- Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based studyCancer Medicine, 2019
- Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase 2 Study ACNS0221International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade GliomasPractical Radiation Oncology, 2019
- Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014JAMA Oncology, 2018
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- miR-429 inhibits glioma invasion through BMK1 suppressionJournal of Neuro-Oncology, 2015
- Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patientsCancer Epidemiology, 2014
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasActa Neuropathologica, 2009
- Analysis of the IDH1 codon 132 mutation in brain tumorsActa Neuropathologica, 2008